Sun Yat-sen University: Liver Neoplasms trials
The registry lists 16 Liver Neoplasms studies with Sun Yat-sen University as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 3Phase 3 4Phase 4 3No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Liver Cancer Prognosis Investigation StudyNot yet recruitingNCT06623734
- Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver MetastasesRecruitingNCT05794971Phase 3
- Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular CarcinomaActive, not recruitingNCT05889949
- Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving ImmunotherapyStatus unknownNCT05620004Phase 1/2
- TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver CancerStatus unknownNCT05220020Phase 3
- Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path PlanningStatus unknownNCT05161624
- Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cmStatus unknownNCT04686942
- HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular CarcinamaStatus unknownNCT04627363Phase 2
- HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTTCompletedNCT04618367Not applicable
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT03164382Phase 3
- Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center StudyCompletedNCT02958592
- Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular CarcinomaStatus unknownNCT00842647
- Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00728078Phase 2/3
- Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00557024Phase 4
- TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular CarcinomaStatus unknownNCT00556803Phase 4
- Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00555334Phase 4